BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12151631)

  • 1. An approach for assessing estrogen receptor-mediated interactions in mixtures of three chemicals: a pilot study.
    Charles GD; Gennings C; Zacharewski TR; Gollapudi BB; Carney EW
    Toxicol Sci; 2002 Aug; 68(2):349-60. PubMed ID: 12151631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of interactions of diverse ternary mixtures in an estrogen receptor-alpha reporter assay.
    Charles GD; Gennings C; Zacharewski TR; Gollapudi BB; Carney EW
    Toxicol Appl Pharmacol; 2002 Apr; 180(1):11-21. PubMed ID: 11922773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the interaction of phytoestrogens and synthetic chemicals: an in vitro/in vivo comparison.
    Charles GD; Gennings C; Tornesi B; Kan HL; Zacharewski TR; Bhaskar Gollapudi B; Carney EW
    Toxicol Appl Pharmacol; 2007 Feb; 218(3):280-8. PubMed ID: 17222880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of the immature rat uterotrophic assay to mixtures of estrogens.
    Tinwell H; Ashby J
    Environ Health Perspect; 2004 Apr; 112(5):575-82. PubMed ID: 15064164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
    Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.
    Ramamoorthy K; Vyhlidal C; Wang F; Chen I; Safe S; McDonnell DP; Leonard LS; Gaido KW
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):93-100. PubMed ID: 9356311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel flexible approach for evaluating fixed ratio mixtures of full and partial agonists.
    Gennings C; Carter WH; Carney EW; Charles GD; Gollapudi BB; Carchman RA
    Toxicol Sci; 2004 Jul; 80(1):134-50. PubMed ID: 15084752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Demonstration of the Uncertainty in Predicting the Estrogenic Activity of Individual Chemicals and Mixtures From an In Vitro Estrogen Receptor Transcriptional Activation Assay (T47D-KBluc) to the In Vivo Uterotrophic Assay Using Oral Exposure.
    Conley JM; Hannas BR; Furr JR; Wilson VS; Gray LE
    Toxicol Sci; 2016 Oct; 153(2):382-95. PubMed ID: 27473340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions.
    Takeyoshi M; Yamasaki K; Sawaki M; Nakai M; Noda S; Takatsuki M
    Toxicol Lett; 2002 Jan; 126(2):91-8. PubMed ID: 11751013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid-hormone-disrupting chemicals: evidence for dose-dependent additivity or synergism.
    Crofton KM; Craft ES; Hedge JM; Gennings C; Simmons JE; Carchman RA; Carter WH; DeVito MJ
    Environ Health Perspect; 2005 Nov; 113(11):1549-54. PubMed ID: 16263510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxylated benzo[a]pyrene metabolites are responsible for in vitro estrogen receptor-mediated gene expression induced by benzo[a]pyrene, but do not elicit uterotrophic effects in vivo.
    Fertuck KC; Matthews JB; Zacharewski TR
    Toxicol Sci; 2001 Feb; 59(2):231-40. PubMed ID: 11158716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the androgen-sensitive MDA-kb2 cell line for assessing complex environmental mixtures.
    Blake LS; Martinović D; Gray LE; Wilson VS; Regal RR; Villeneuve DL; Ankley GT
    Environ Toxicol Chem; 2010 Jun; 29(6):1367-76. PubMed ID: 20821581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line.
    Legler J; van den Brink CE; Brouwer A; Murk AJ; van der Saag PT; Vethaak AD; van der Burg B
    Toxicol Sci; 1999 Mar; 48(1):55-66. PubMed ID: 10330684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive effects of levonorgestrel and ethinylestradiol on brain aromatase (cyp19a1b) in zebrafish specific in vitro and in vivo bioassays.
    Hinfray N; Tebby C; Garoche C; Piccini B; Bourgine G; Aït-Aïssa S; Kah O; Pakdel F; Brion F
    Toxicol Appl Pharmacol; 2016 Sep; 307():108-114. PubMed ID: 27491593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the combined effects of multiple estrogenic chemicals on MCF-7 human breast cancer cells and a preliminary molecular exploration of the estrogenic proliferative effects and related gene expression.
    Yuan S; Huang C; Ji X; Ma M; Rao K; Wang Z
    Ecotoxicol Environ Saf; 2018 Sep; 160():1-9. PubMed ID: 29783106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of triclosan on the uterotrophic response to extended doses of ethinyl estradiol in the weanling rat.
    Louis GW; Hallinger DR; Stoker TE
    Reprod Toxicol; 2013 Apr; 36():71-7. PubMed ID: 23261820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the reporter gene assay for ER-alpha antagonists with the immature rat uterotrophic assay of 10 chemicals.
    Yamasaki K; Takeyoshi M; Yakabe Y; Sawaki M; Takatsuki M
    Toxicol Lett; 2003 Apr; 142(1-2):119-31. PubMed ID: 12765246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development.
    Owens JW; Ashby J
    Crit Rev Toxicol; 2002; 32(6):445-520. PubMed ID: 12487363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic (cyp19a1b-GFP) zebrafish embryos as a tool for assessing combined effects of oestrogenic chemicals.
    Petersen K; Fetter E; Kah O; Brion F; Scholz S; Tollefsen KE
    Aquat Toxicol; 2013 Aug; 138-139():88-97. PubMed ID: 23721851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.